Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis
Autor/a
Garin, Noe
Zarate-Tamames, Borja
Gras-Martin, Laura
Milà, Raimon
Crespo-Lessmann, Astrid
Curto, Elena
Hernández Hernández, Marta
Mestres Miralles, Concepción
Plaza Moral, Vicente
Otros/as autores/as
Universitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna
Fecha de publicación
2023-03Resumen
We conducted a systematic review and meta-analysis to gain insight into the characteristics and clinical impact of electronic monitoring devices of inhalers (EMDs) and their clinical interventions in adult patients with asthma or COPD. The search included PubMed, Web of Science, Cochrane, Scopus and Embase databases, as well as official EMDs websites. We found eight observational studies and ten clinical trials, assessing a wide range of clinical outcomes. Results from the meta-analysis on adherence to inhalers in a period over three months were favourable in the EMD group (fixed effects model: SMD: 0.36 [0.25–0.48]; random effects model SMD: 0.41 [0.22–0.60]). An exploratory meta-analysis found an improvement in ACT score (fixed effect model SMD: 0.25 [0.11–0.39]; random effects model: SMD: 0.47 [−0.14–1.08]). Other clinical outcomes showed mixed results in the descriptive analyses. The findings of this review highlight the benefits of EMDs in the optimization of adherence to inhaled therapy as well as the potential interest in other clinical outcomes.
Tipo de documento
Artículo
Versión del documento
Versión publicada
Lengua
English
Materias (CDU)
615 - Farmacología. Terapéutica. Toxicología. Radiología
616.2 - Patología del aparato respiratorio
Palabras clave
Asma
Pulmons -- Malalties obstructives
COPD
Inhaladors
Medicaments -- Monitoratge
Metaanàlisi
Páginas
25 p.
Publicado por
MDPI
Publicado en
Pharmaceuticals, 2023, vol. 16, núm. 3, 414
Este ítem aparece en la(s) siguiente(s) colección(ones)
Derechos
© L'autor/a
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by/4.0/